Home › Lymphoma
Pag-aaral pangklinika para sa Lymphoma na nagre-recruit sa U.S.
140 pag-aaral para sa Lymphoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX34 pag-aaral
- Boston, MA34 pag-aaral
- New York City, NY33 pag-aaral
- Washington, DC23 pag-aaral
- Baldwin Park, CA22 pag-aaral
- Chicago, IL19 pag-aaral
- Durham, NC17 pag-aaral
- St. Louis, MO15 pag-aaral
- Cleveland, OH13 pag-aaral
- Seattle, WA13 pag-aaral
- Atlanta, GA13 pag-aaral
- Philadelphia, PA13 pag-aaral
- Edison, NJ12 pag-aaral
- Salt Lake City, UT11 pag-aaral
- Miami, FL11 pag-aaral
- Columbus, OH11 pag-aaral
- Queens, NY10 pag-aaral
- Pittsburgh, PA10 pag-aaral
- Rochester, MN10 pag-aaral
- Los Angeles, CA10 pag-aaral
- Dallas, TX10 pag-aaral
- Mountain View, CA10 pag-aaral
- Milwaukee, WI10 pag-aaral
- Nashville, TN10 pag-aaral
- Greenburgh, NY9 pag-aaral
- Portland, OR9 pag-aaral
- Cincinnati, OH9 pag-aaral
- Denver, CO9 pag-aaral
- Staten Island, NY8 pag-aaral
- East Norwalk, CT8 pag-aaral
- Aurora, CO8 pag-aaral
- Birmingham, AL8 pag-aaral
- New Rochelle, NY7 pag-aaral
- Omaha, NE7 pag-aaral
- Phoenix, AZ7 pag-aaral
- Tampa, FL7 pag-aaral
- San Antonio, TX7 pag-aaral
- New Haven, CT7 pag-aaral
- Buffalo, NY6 pag-aaral
- Winston-Salem, NC6 pag-aaral
Ayos sa estado
- Alabama9 pag-aaral
- Arizona11 pag-aaral
- Arkansas3 pag-aaral
- California40 pag-aaral
- Colorado16 pag-aaral
- Connecticut7 pag-aaral
- District of Columbia7 pag-aaral
- Florida24 pag-aaral
- Georgia16 pag-aaral
- Illinois22 pag-aaral
- Indiana5 pag-aaral
- Iowa6 pag-aaral
- Kansas6 pag-aaral
- Kentucky4 pag-aaral
- Maryland21 pag-aaral
- Massachusetts34 pag-aaral
- Michigan13 pag-aaral
- Minnesota13 pag-aaral
- Missouri17 pag-aaral
- Nebraska7 pag-aaral
- New Jersey18 pag-aaral
- New Mexico3 pag-aaral
- New York41 pag-aaral
- North Carolina22 pag-aaral
- Ohio28 pag-aaral
- Oklahoma4 pag-aaral
- Oregon9 pag-aaral
- Pennsylvania22 pag-aaral
- South Carolina4 pag-aaral
- Tennessee14 pag-aaral
- Texas44 pag-aaral
- Utah14 pag-aaral
- Virginia10 pag-aaral
- Washington13 pag-aaral
- Wisconsin13 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT02974647A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Nagre-recruitPhase 1/2
6 Months – 17 Years · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT02332668Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00923507A Phase 2 Study of Epcoritamab in Patients With Follicular Lymphoma and Marginal Zone Lymphoma Not Accomplishing a Complete Response With Upfront Therapy
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06510361Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Nagre-recruitPhase 1/2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03223610A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05773040Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06218602Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03258567Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04301076Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06856226Living Well With Lymphoma
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06047626Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 5 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT05237986HPC Offered for PRESERVE Expansion
Nagre-recruitObservasyonal na pag-aaral
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07145411A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07015242A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06084936cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05366881A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07188558A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07221500A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06520098Mosaic Trial for Stem Cell Transplant Recipients
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06960993Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT05371132Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07583810Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Nagre-recruitObservasyonal na pag-aaral
Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06131801A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
Nagre-recruitPhase 2
1 Month – 17 Years · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT04570423HEME Home Transfusion Program
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06487247Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.